Is Pharvaris N.V. (PHVS) a Buy, Sell, or Hold?
NASDAQ : PHVS
Pharvaris N.V.
$35.16 USD
$0.74 (2.15%)
- Volume
- 60.03K
- Average Volume
- 428.4K
- Market Capitalization
- $2.46B
- P/E Ratio
- -10.68
- Dividend Yield
- 0.00%
- Price Target
- $52.00
- Year High
- $36.60
- Year Low
- $19.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.24
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
25
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
87
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$560.3K
PHVS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
PHVS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Modig Berndt | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 34.9714 | 2026-07-15 |
| Lu Peng | officer: Chief Medical Officer | 2026-07-11 | F-InKind | 35.07 | 2026-07-14 |
| Lu Peng | officer: Chief Medical Officer | 2026-07-12 | F-InKind | 35.07 | 2026-07-14 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-06-29 | S-Sale | 35.0533 | 2026-07-01 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-06-30 | S-Sale | 35.4926 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | S-Sale | 35.0481 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-30 | S-Sale | 35.4896 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-30 | M-Exempt | 8.05 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 8.05 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 8.05 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-30 | M-Exempt | 2.59 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 8.05 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | S-Sale | 35.0491 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-30 | S-Sale | 35.4797 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 2.59 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 2.59 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | S-Sale | 35.1242 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-30 | M-Exempt | 8.05 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 2.59 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-29 | M-Exempt | 2.59 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-30 | M-Exempt | 2.59 | 2026-07-01 |
| Lesage Anne | officer: Chief Early Development | 2026-06-25 | S-Sale | 35.1242 | 2026-06-29 |
| Lesage Anne | officer: Chief Early Development | 2026-06-25 | M-Exempt | 8.05 | 2026-06-29 |
| Lesage Anne | officer: Chief Early Development | 2026-06-25 | M-Exempt | 8.05 | 2026-06-29 |
| Lesage Anne | officer: Chief Early Development | 2026-06-25 | M-Exempt | 2.59 | 2026-06-29 |
| Lesage Anne | officer: Chief Early Development | 2026-06-25 | S-Sale | 35.1194 | 2026-06-29 |
| Lesage Anne | officer: Chief Early Development | 2026-06-25 | M-Exempt | 2.59 | 2026-06-29 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-06-29 | S-Sale | 35.1041 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-25 | M-Exempt | 2.59 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-26 | M-Exempt | 2.59 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-25 | M-Exempt | 2.59 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-26 | M-Exempt | 2.59 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-25 | S-Sale | 34.4547 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-25 | S-Sale | 35.0913 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-26 | S-Sale | 34.0032 | 2026-06-29 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-18 | M-Exempt | 2.59 | 2026-06-23 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-18 | M-Exempt | 2.59 | 2026-06-23 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-18 | S-Sale | 34 | 2026-06-23 |
| Modig Berndt | director, officer: Chief Executive Officer | 2026-06-15 | S-Sale | 31.0484 | 2026-06-17 |
| Modig Berndt | director, officer: Chief Executive Officer | 2026-06-15 | S-Sale | 31.46 | 2026-06-17 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-12 | F-InKind | 32.2 | 2026-06-16 |
| Lu Peng | officer: Chief Medical Officer | 2026-06-11 | F-InKind | 31.51 | 2026-06-15 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-06-04 | S-Sale | 30.8708 | 2026-06-08 |
| Monges Viviane | director | 2026-05-21 | S-Sale | 30.2941 | 2026-05-26 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-05-22 | M-Exempt | 20 | 2026-05-26 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-05-21 | M-Exempt | 20 | 2026-05-26 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-05-21 | S-Sale | 30.6021 | 2026-05-26 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-05-22 | S-Sale | 30.737 | 2026-05-26 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-05-21 | M-Exempt | 20 | 2026-05-26 |
| Nijdam Anna | officer: Principal Accounting Officer | 2026-05-22 | M-Exempt | 20 | 2026-05-26 |
| Nassif David W. | officer: CFO / CLO | 2026-05-21 | S-Sale | 30.3076 | 2026-05-26 |
| Bjork Elisabeth | director | 2026-05-20 | M-Exempt | 8.05 | 2026-05-22 |
| Bjork Elisabeth | director | 2026-05-20 | S-Sale | 29.3166 | 2026-05-22 |
| Bjork Elisabeth | director | 2026-05-20 | M-Exempt | 8.05 | 2026-05-22 |
| Modig Berndt | 2026-05-18 | 0 | 2026-05-22 | ||
| Modig Berndt | director, officer: Chief Executive Officer | 2026-05-18 | S-Sale | 29.222 | 2026-05-20 |
| Glassman Robert | director | 2026-05-15 | M-Exempt | 22.31 | 2026-05-19 |
| Glassman Robert | director | 2026-05-15 | S-Sale | 29.8314 | 2026-05-19 |
| Glassman Robert | director | 2026-05-15 | S-Sale | 29.8167 | 2026-05-19 |
| Glassman Robert | director | 2026-05-15 | M-Exempt | 22.31 | 2026-05-19 |
| Abele Stefan Andreas | officer: Chief Technical Ops Officer | 2026-05-15 | S-Sale | 29.8199 | 2026-05-19 |
| Souverijns Wim | officer: Chief Commercial Officer | 2026-05-15 | S-Sale | 29.9163 | 2026-05-19 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-11 | F-InKind | 30.09 | 2026-05-13 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-12 | F-InKind | 29.95 | 2026-05-13 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-01 | M-Exempt | 2.59 | 2026-05-05 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-01 | M-Exempt | 2.59 | 2026-05-05 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-01 | M-Exempt | 2.59 | 2026-05-05 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-01 | S-Sale | 30.1637 | 2026-05-05 |
| Lu Peng | officer: Chief Medical Officer | 2026-05-01 | S-Sale | 31 | 2026-05-05 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-04-29 | S-Sale | 30.0692 | 2026-05-01 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-04-30 | S-Sale | 30.3024 | 2026-05-01 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-04-30 | S-Sale | 31.0321 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-29 | S-Sale | 30.062 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-30 | S-Sale | 30.2557 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-30 | M-Exempt | 8.05 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-30 | M-Exempt | 8.05 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-30 | M-Exempt | 2.59 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-30 | S-Sale | 30.2558 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-29 | S-Sale | 30.0758 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-29 | M-Exempt | 2.59 | 2026-05-01 |
| Lesage Anne | officer: Chief Early Development | 2026-04-30 | M-Exempt | 2.59 | 2026-05-01 |
| Lu Peng | officer: Chief Medical Officer | 2026-04-29 | M-Exempt | 2.59 | 2026-05-01 |
| Lu Peng | officer: Chief Medical Officer | 2026-04-30 | M-Exempt | 2.59 | 2026-05-01 |
| Lu Peng | officer: Chief Medical Officer | 2026-04-30 | M-Exempt | 2.59 | 2026-05-01 |
| Lu Peng | officer: Chief Medical Officer | 2026-04-29 | M-Exempt | 2.59 | 2026-05-01 |
| Lu Peng | officer: Chief Medical Officer | 2026-04-30 | S-Sale | 30.2418 | 2026-05-01 |
| Lu Peng | officer: Chief Medical Officer | 2026-04-29 | S-Sale | 30.0649 | 2026-05-01 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-04-22 | S-Sale | 30.0541 | 2026-04-24 |
| Schikan Johannes Gerardus Christiaan Petrus | director | 2026-04-23 | S-Sale | 30.03 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | S-Sale | 30.0511 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-23 | S-Sale | 30.03 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | M-Exempt | 8.05 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | M-Exempt | 8.05 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | M-Exempt | 2.59 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-23 | M-Exempt | 2.59 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | S-Sale | 30 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | S-Sale | 30.0517 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-23 | S-Sale | 30.03 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-22 | M-Exempt | 2.59 | 2026-04-24 |
| Lesage Anne | officer: Chief Early Development | 2026-04-23 | M-Exempt | 2.59 | 2026-04-24 |